Skip to main content
Back
Watch Compare

WINDTREE THERAPEUTICS INC /DE/

Data quality: 83%
WINT
OTC Manufacturing Chemicals
$0.02
▲ $0.00 (29.06%)
Mkt Cap: 394,392.0
Price
$0.01
Mkt Cap
394,392.0
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -15.12 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-519.54%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio0.33
Interest Coverage-68.64

Valuation

PE (TTM)
-0.01
Above sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E 0.0 -1.5
P/B — 1.6
ROE % — -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42024 -$39.00 N/A —
Q32024 -$113.50 -$211.50 -86.3%
Q22024 -$405.50 -$1,045.50 -157.8%
Q12024 N/A $1,099.00 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -39.99 M
ROE N/A ROA -167.31%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -15.12 M
ROIC -519.54% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.33
Interest Coverage -68.64 Asset Turnover N/A
Working Capital -14.70 M Tangible Book Value -11.61 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.01 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3834.00%
Market Cap 394,392.0 Enterprise Value 190,392.0
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -0.46 OCF / Share -0.46
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 37.81%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -1.79 M -20.29 M -39.21 M -67.64 M -32.57 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -26.14 M -20.60 M -41.33 M -77.28 M -30.32 M
EBITDA — — — — —
R&D Expenses 16.28 M 8.34 M 11.10 M 17.79 M 15.37 M
SG&A Expenses 8.74 M 9.20 M 10.79 M 14.47 M 14.94 M
D&A — — — — —
Interest Expense 235,000.0 50,000.0 53,000.0 114,000.0 125,000.0
Income Tax -6,000.0 0.0 -1.37 M -9.99 M —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 27.88 M 32.41 M 37.95 M 74.79 M 112.89 M
Total Liabilities 14.70 M 29.02 M 27.94 M 32.91 M 43.33 M
Shareholders' Equity 10.00 M 3.39 M 10.01 M 41.88 M 69.55 M
Total Debt — — — — —
Cash & Equivalents 1.78 M 4.32 M 6.17 M 22.35 M 16.93 M
Current Assets 2.57 M 5.38 M 7.38 M 23.49 M 18.12 M
Current Liabilities 5.72 M 4.00 M 2.46 M 4.92 M 6.13 M